BEAM BEAM THERAPEUTICS INC Earnings Reports 8-K Filing 2025 - Financial Update Beam Therapeutics Inc. estimates it had approximately $850.7 million in cash and marketable securities as of December 31, 2024, and announced progress in its base editing portfolio during an investor presentation.Get access to all SEC 8-K filings of the BEAM THERAPEUTICS INC